Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.7b00359
Abstract: Inhibition of the protein-protein interaction between B-cell lymphoma 6 (BCL6) and corepressors has been implicated as a therapeutic target in diffuse large B-cell lymphoma (DLBCL) cancers and profiling of potent and selective BCL6 inhibitors are…
read more here.
Keywords:
lymphoma bcl6;
pyrazolo pyrimidine;
bcl6 binders;
cell ... See more keywords